How immune cells “sniff out” pathogens
Immune cells are capable of detecting infections just like a sniffer dog, using special sensors known as Toll-like receptors, or...
adminph
SMC recommends Yselty for treating uterine fibroids
New treatment option approved for women in Scotland The Scottish Medicines Consortium (SMC) has recommended Yselty (linzagolix) for treating moderate...
Scottish medicines consortium approves CAR T-cell therapy for blood cancer
First car t-cell therapy accepted for second-line treatment in Scotland The Scottish Medicines Consortium (SMC) has approved Kite’s CAR T-cell...
New antibody could be promising cancer treatment
Researchers at Uppsala University and KTH Royal Institute of Technology have developed a new form of precision medicine, an antibody,...
Researchers make glioblastoma cells visible to attacking immune cells
Even treated with the most advanced therapies, patients with glioblastoma - an aggressive brain cancer - typically survive less than...
New study to assess mpox vaccine in pregnant women and infants
Trial to evaluate safety and efficacy of MVA-BN vaccine A new scientific trial evaluating Bavarian Nordic’s mpox vaccine in pregnant...
Elsevier backs Pistoia Alliance for AI in drug discovery
New initiatives to tackle AI-related challenges in life sciences Elsevier, a leader in information and analytics, has announced its support...
Scientists discover how specific E. coli bacteria drive colon cancer
Scientists have uncovered how certain E. coli bacteria in the gut promote colon cancer by binding to intestinal cells and...
Arcellx to present positive data on multiple myeloma treatments
Phase 1 and 2 studies show promising results for anito-cel therapy Arcellx Inc, a biotechnology firm focused on cell therapy...
MHRA grants approval for bladder cancer drug erdafitinib
New therapy targets specific genetic alterations, promises extended survival Johnson & Johnson has announced that the UK’s Medicines and Healthcare...
Bayer Foundation announces Science Awards winners of 2024
Professor Meritxell Huch receives this year's Otto Bayer Award. The Otto Bayer Award is presented alternating with the Hansen Family...
A rare opportunity
Importance of continuous collaboration with rare disease communities At Blueprint Medicines, we aim to make a significant difference in patients’...
Dr Jane Rhodes
AstronauTx has appointed Dr Jane Rhodes as Chief Executive Officer AstronauTx has appointed Dr Jane Rhodes as Chief Executive Officer (CEO) and member of the Board,...
An old drug with new tricks
As the hunt for effective cancer therapies intensifies, some scientists are turning back to look at old drugs in a...
Anthony Hemmerdinger
Walgreens Boots Alliance appoints Anthony Hemmerdinger as MD, UK and Ireland Walgreens Boots Alliance has announced the appointment of Anthony Hemmerdinger as Managing Director of...
Trial transformers
Building strong partnerships with sites for more effective clinical trials When I first entered the clinical research industry more than...
New anti-cancer agent works without oxygen
"As tumors grow very quickly, consume a lot of oxygen and their vascular growth can't necessarily keep pace, they often...
GSK enters agreement to acquire CMG1A46 from Chimagen Biosciences to expand immunology pipeline
GSK plc (LSE/NYSE: GSK) and Chimagen Biosciences (Chimagen), a privately held biotechnology company, announced an agreement for GSK to acquire...
NICE recommends remote monitoring technology for heart failure patients
Heart failure accounted for approximately 90,000 hospital admissions in England in 2019 to 2020 The National Institute for Health and...
UK dementia clinical trial participation set to boost by ‘tens of thousands’
The new Dementia Trials Accelerator is set to receive £20m of government funding The Dementia Trials Accelerator, led by the...
